This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States
The drug ACULAR contains one active pharmaceutical ingredient (API):
|
1
Ketorolac trometamol
UNII 4EVE5946BQ - KETOROLAC TROMETHAMINE
|
|
Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ACULAR Eye drops, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01BC05 | Ketorolac | S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501000101176310, 501006201131318, 501006202136313, 501007301170313, 501007302177311, 501007303173311 |
| Country: CA | Health Products and Food Branch | Identifier(s): 01968300, 02248722 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 27-947-03-08 |
| Country: EE | Ravimiamet | Identifier(s): 1006120 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61690 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 63866361 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 138242, 140407, 161342, 36933 |
| Country: HK | Department of Health Drug Office | Identifier(s): 57634 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 10336, 13023, 13045 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 13641751 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 34436 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 2905 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100135085 |
| Country: SG | Health Sciences Authority | Identifier(s): 11189P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699490561027 |
| Country: US | FDA, National Drug Code | Identifier(s): 0023-2181, 0023-9277 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
